Clinical diaries in COPD: Compliance and utility in predicting acute exacerbations

International Journal of COPD

Volumn 7, Issue , 2012, Pages 427-435

  Walters, E Haydn ^a   Walters, Julia ^a   Wills, Karen E ^a   Robinson, Andrew ^b   Wood Baker, Richard ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Daily diary; Secondary prevention

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DATA COLLECTION METHOD; DISEASE EXACERBATION; DYSPNEA; EDUCATIONAL STATUS; EMERGENCY CARE; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; PHYSICAL ACTIVITY; PREDICTION; PREDICTIVE VALUE; RISK ASSESSMENT; SPUTUM; AREA UNDER THE CURVE; DISEASE COURSE; FORECASTING; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; REPRODUCIBILITY; SECONDARY PREVENTION; SELF REPORT;

AREA UNDER CURVE; DISEASE PROGRESSION; FEMALE; FORECASTING; HUMANS; MALE; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SECONDARY PREVENTION; SELF REPORT;

EID: 84871679170     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S32222     Document Type: Article

References (37)

1. Bolger N, Davis A, Rafaeli E. Diary methods: capturing life as it is lived. Annu Rev Psychol. 2003;54:579-616.
2. Shiffman S, Stone A, Hufford M. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1-32.
3. Stone AA, Shiffman S. Capturing momentary, self-report data: a proposal for reporting guidelines. Ann Behav Med. 2002;24: 236-243.
4. Aaron LA, Mancl L, Turner JA, Sawchuk CN, Klein KM. Reasons for missing interviews in the daily electronic assessment of pain, mood, and stress. Pain. 2004;109:389-398.
5. Burke LE, Sereika SM, Music E, Warziski M, Styn MA, Stone A. Using instrumented paper diaries to document self-monitoring patterns in weight loss. Contemp Clin Trials. 2008;29:182-193.
6. Broderick JE, Stone AA. Paper and electronic diaries: too early for conclusions on compliance rates and their effects - comment on Green, Rafaeli, Bolger, Shrout, and Reis (2006). Psychol Methods. 2006;11: 106-111.
7. Burke LE, Swigart V, Warziski Turk M, Derro N, Ewing LJ. Experiences of self-monitoring: successes and struggles during treatment for weight loss. Qual Health Res. 2009;19:815-828.
8. Jiang H, Han J, Zhu Z, Xu W, Zheng J, Zhu Y. Patient compliance with assessing and monitoring of asthma. J Asthma. 2009;46: 1027-1031.
9. Broderick JE, Schwartz JE, Shiffman S, Hufford MR, Stone AA. Signaling does not adequately improve diary compliance. Ann Behav Med. 2003;26:139-148.
10. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax. 1997; 52 Suppl 5:S1-S28.
11. McKenzie DK, Frith PA, Burdon JG, Town GI. The COPDX plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Aust. 2003;178 Suppl:S7-S39.
12. Rennard SI, Schachter N, Strek M, Rickard K, Amit O. Cilomilast for COPD. Results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006;129(1):5-66.
13. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418-1422.
14. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008;177:396-401.
15. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
16. Leidy NK, Wilcox TK, Jones PW, et al. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measure. Value Health. 2010;13:965-975.
17. Effing TW, Kerstjens HAM, Monninkhof EM, et al. Definitions of exacerbations. Chest. 2009;136:918-923.
18. US Food and Drug Administration. Draft guidance for industry: acute bacterial exacerbations of chronic bronchitis in patients with chronic obstructive pulmonary disease; developing antimicrobial drugs for treatment, 2008. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070935.pdf. Accessed May 16, 2012.
19. Cummings E, Robinson A, Courtney-Pratt H, et al. Pathways Home: comparing voluntary IT and non-IT users participating in a mentored self-management project. Stud Health Technol Inform. 2010;160: 23-27.
20. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85: 751-758.
21. Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The breath-lessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest. 2003;124:2182-2191.
22. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;21 Suppl 4:S46-S53.
23. Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest. 2006;130:133-142.
24. O'Reilly JF, Williams AE, Holt K, Rice L. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J. 2006;15:346-353.
25. Piasecki TM, Hufford MR, Solhan M, Trull TJ. Assessing clients in their natural environments with electronic diaries: rationale, benefits, limitations, and barriers. Psychol Assess. 2007;19:25-43.
26. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63: 831-838.
27. Willis KF, Robinson A, Wood-Baker R, Turner P, Walters EH. Participating in research: exploring participation and engagement in a study of self-management for people with chronic obstructive pulmonary disease. Qual Health Res. 2011;21:1273-1282.
28. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
29. Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G. Impact on patients' health status following early identification of a COPD exacerbation. Eur Respir J. 2007;30:907-913.
30. Tynan AJ, Lane SJ. COPD: illness severity, resource utilisation and cost. Ir Med J. 2005;98:44-45.
31. Leidy NK, Wilcox TK, Jones PW, et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med. 2011;183:323-329.
32. Calverley PMA. Minimal clinically important exacerbations of COPD. COPD. 2005;2:143-148.
33. van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of discontinuation of inhaled corti-costeroids in patients with chronic obstructive pulmonary dis-ease: the COPE study. Am J Respir Crit Care Med. 2002;166: 1358-1363.
34. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176: 532-555.
35. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117:398S-401S.
36. Effing T, Monninkhof EM, van der Valk PD, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007;4:CD002990. DUPLICATE OF 37.
37. Walters J, Turnock A, Walters E, Wood-Baker R. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2010;5:CD005074.